In the same year, Kourtidis et al. have carried out a shRNA screen targeting 150 genes that are co-overexpressed with HER2 based on previous meta-analyses and discovered that both NR1D1 and PBP are novel survival factors essential for HER2+ breast cancer cells [97]. Here, ERBB2 is linked to breast carcinoma.